Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
- 29 February 1992
- journal article
- clinical trial
- Published by Elsevier in Bone and Mineral
- Vol. 16 (2) , 131-138
- https://doi.org/10.1016/0169-6009(92)90883-f
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Differential effects of aging and disease on trabecular and compact bone density of the radiusBone, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronateJournal of Bone and Mineral Research, 1989
- Pathogenesis, Prevention, and Treatment of OsteoporosisAnnual Review of Medicine, 1989
- Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonateBone, 1988
- The proportion of trabecular bone in human vertebraeJournal of Bone and Mineral Research, 1987
- Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis.Journal of Clinical Investigation, 1981
- A quantitative study of the effects of prolonged calcitonin treatment on alveolar bone remodelling in the golden hamsterCalcified Tissue International, 1977